We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+16.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$494M
AUM Growth
+$42.7M
Cap. Flow
+$6.06M
Cap. Flow %
1.23%
Top 10 Hldgs %
43.7%
Holding
176
New
26
Increased
32
Reduced
32
Closed
5

Top Buys

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$7.68M
2
UBER icon
Uber
UBER
+$7.63M
3
GEHC icon
GE HealthCare
GEHC
+$6.75M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.54M
5
FISV
Fiserv Inc
FISV
+$4.7M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.48M
2
ROK icon
Rockwell Automation
ROK
+$6.92M
3
SLB icon
SLB Ltd
SLB
+$6.42M
4
CVS icon
CVS Health
CVS
+$6.06M
5
SBUX icon
Starbucks
SBUX
+$2.69M

Sector Composition

Rank Sector Weight
1 Technology 39.93%
2 Healthcare 14.36%
3 Financials 12.45%
4 Communication Services 11%
5 Consumer Discretionary 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
26
Oracle
ORCL
$435B
$8.63M 1.75%
61,146
+758
+1% +$94.1K
NEE icon
27
NextEra Energy
NEE
$171B
$8.34M 1.69%
117,710
+443
+0.4% +$31.4K
SYK icon
28
Stryker
SYK
$127B
$8.04M 1.63%
23,637
+105
+0.4% +$35.6K
UBER icon
29
Uber
UBER
$161B
$7.98M 1.62%
+109,783
New +$7.63M
LHX icon
30
L3Harris
LHX
$48.9B
$7.8M 1.58%
34,737
+1,251
+4% +$270K
TMO icon
31
Thermo Fisher Scientific
TMO
$230B
$7.43M 1.51%
13,436
+20
+0.1% +$11.5K
PH icon
32
Parker-Hannifin
PH
$125B
$7.24M 1.47%
+14,321
New +$7.68M
MS icon
33
Morgan Stanley
MS
$337B
$7M 1.42%
72,034
+47
+0.1% +$4.47K
BLK icon
34
Blackrock
BLK
$180B
$6.67M 1.35%
8,468
-20
-0.2% -$15.6K
ROL icon
35
Rollins
ROL
$17.5B
$6.63M 1.34%
135,875
+1,379
+1% +$63.7K
GEHC icon
36
GE HealthCare
GEHC
$32.4B
$6.45M 1.31%
+82,800
New +$6.75M
ULTA icon
37
Ulta Beauty
ULTA
$22.1B
$5.86M 1.19%
15,192
-296
-2% -$120K
MRK icon
38
Merck
MRK
$366B
$3.4M 0.69%
27,490
– –
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.19T
$2.82M 0.57%
15,400
– –
QCOM icon
40
Qualcomm
QCOM
$175B
$2.55M 0.52%
12,803
– –
REGN icon
41
Regeneron Pharmaceuticals
REGN
$81.8B
$2.42M 0.49%
2,308
– –
BRK.B icon
42
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.55M 0.31%
3,814
-15
-0.4% -$6.13K
ASML icon
43
ASML
ASML
$651B
$1.43M 0.29%
1,400
– –
WMT icon
44
Walmart Inc
WMT
$820B
$1.32M 0.27%
19,560
-9,000
-32% -$567K
APD icon
45
Air Products & Chemicals
APD
$68.6B
$918K 0.19%
3,560
– –
ZBRA icon
46
Zebra Technologies
ZBRA
$16.9B
$872K 0.18%
2,825
– –
MCD icon
47
McDonald's
MCD
$188B
$863K 0.17%
3,388
+119
+4% +$31.6K
JNJ icon
48
Johnson & Johnson
JNJ
$646B
$836K 0.17%
5,721
-527
-8% -$78.4K
SSNC icon
49
SS&C Technologies
SSNC
$19.6B
$831K 0.17%
13,272
– –
SPY icon
50
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$806K 0.16%
1,483
+5
+0.3% +$2.62K
1
2
3 4 5

Similar funds

FGN
Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return
SFAM
Springhill Fund Asset Management Hong Kong $20.9M AUM
NTIMCH
New Thinking Investment Management Company (HK) Hong Kong $20.4M AUM 4.24% 1-Year Est. Return
GDCML
Galaxy Digital Capital Management LP New York $13.5M AUM
AA
AlphaQ Advisors Winter Park, Florida $41.7M AUM 12.96% 1-Year Est. Return
GIS
Grayhawk Investment Strategies Calgary, Alberta, Canada $43.9M AUM 6.23% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Cyrus J. Lawrence's Q2 2024 Portfolio in Review

As of Q2 2024, Cyrus J. Lawrence held 176 positions worth $494M, up 9.5% from $451M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cyrus J. Lawrence's Q2 2024 filing shows 26 new, 32 increased, 32 reduced and 5 closed positions. Its largest new stake was Parker-Hannifin: 14,321 shares worth $7.24M. The largest sale was UnitedHealth, an estimated $7.48M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Cyrus J. Lawrence's largest Q2 2024 buy was Parker-Hannifin: 14,321 shares worth $7.24M.
  • Cyrus J. Lawrence added most to Vertex Pharmaceuticals in Q2 2024, an estimated $5.54M increase.
  • Cyrus J. Lawrence's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $7.48M.
  • Cyrus J. Lawrence fully exited Mondelez International in Q2 2024, selling an estimated $70K.
  • Cyrus J. Lawrence's ten largest holdings make up 44% of its $494M portfolio in Q2 2024.
  • Cyrus J. Lawrence opened 26 new positions and closed 5 in Q2 2024.
  • Cyrus J. Lawrence's portfolio value rose 9.5% quarter-over-quarter to $494M.

Based on Cyrus J. Lawrence's 13F filing for Q2 2024, filed 13 Aug 2024.